$CRBU Income Statement | Understand Stock

$CRBU

$0.46 -$0.03 (6.4%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Licensing and collaboration revenue (including $2,487 and $4,110 for years ended December 31, 2025, and December 31, 2024, respectively, from related parties)
Operating expenses:
Research and development
General and administrative
Impairment charges
Total operating expenses
Loss from operations
Other (expense) income
Interest income
Interest expense
Change in fair value of equity securities
Change in fair value of the MSKCC success payments liability
Gain on extinguishment of PPP Loan
Impairment Of Equity Method Investment
Other income, net
Total other (expense) income

Net loss before benefit from income taxes
Benefit from income taxes
Net loss
Net unrealized loss on available-for-sale marketable securities
Other comprehensive (loss) income
Net unrealized (loss) gain on available-for-sale marketable securities, net of tax
Net comprehensive loss
Net loss per share, basic and diluted
Weighted-average common shares outstanding, basic and diluted
Net loss per share, basic (in dollars per share)
Net loss per share, diluted (in dollars per share)
Weighted average common shares outstanding, basic (in shares)
Weighted average common shares outstanding, diluted (in shares)

Comments